Cargando…
Effects of pre-existing orthopoxvirus-specific immunity on the performance of Modified Vaccinia virus Ankara-based influenza vaccines
The replication-deficient orthopoxvirus modified vaccinia virus Ankara (MVA) is a promising vaccine vector against various pathogens and has an excellent safety record. However, pre-existing vector-specific immunity is frequently suggested to be a drawback of MVA-based vaccines. To address this issu...
Autores principales: | Altenburg, Arwen F., van Trierum, Stella E., de Bruin, Erwin, de Meulder, Dennis, van de Sandt, Carolien E., van der Klis, Fiona R. M., Fouchier, Ron A. M., Koopmans, Marion P. G., Rimmelzwaan, Guus F., de Vries, Rory D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915537/ https://www.ncbi.nlm.nih.gov/pubmed/29692427 http://dx.doi.org/10.1038/s41598-018-24820-2 |
Ejemplares similares
-
Modified Vaccinia Virus Ankara Preferentially Targets Antigen Presenting Cells In Vitro, Ex Vivo and In Vivo
por: Altenburg, Arwen F., et al.
Publicado: (2017) -
Matrix-M™ adjuvant enhances immunogenicity of both protein- and modified vaccinia virus Ankara-based influenza vaccines in mice
por: Magnusson, Sofia E., et al.
Publicado: (2018) -
Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases
por: Altenburg, Arwen F., et al.
Publicado: (2014) -
Induction of Influenza (H5N8) Antibodies by Modified Vaccinia Virus Ankara H5N1 Vaccine
por: de Vries, Rory D., et al.
Publicado: (2015) -
Evasion of Influenza A Viruses from Innate and Adaptive Immune Responses
por: van de Sandt, Carolien E., et al.
Publicado: (2012)